Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease

Paweł Mochalski, Julian King, Matthias Haas, Karl Unterkofler, Anton Amann, Gert Mayer

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Monitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment. Methods. Gas chromatography with mass spectrometric detection coupled with solid-phase microextraction as pre-concentration method. Results: A total of 60 VOCs were reliably identified and quantified in blood and breath of CKD patients. Excluding contaminants, six compounds (isoprene, dimethyl sulfide, methyl propyl sulfide, allyl methyl sulfide, thiophene and benzene) changed their blood and breath levels during the hemodialysis treatment. Conclusions: Uremic breath and blood patterns were found to be notably affected by the contaminants from the extracorporeal circuits and hospital room air. Consequently, patient exposure to a wide spectrum of volatile species (hydrocarbons, aldehydes, ketones, aromatics, heterocyclic compounds) is expected during hemodialysis. Whereas highly volatile pollutants were relatively quickly removed from blood by exhalation, more soluble ones were retained and contributed to the uremic syndrome. At least two of the species observed (cyclohexanone and 2-propenal) are uremic toxins. Perhaps other volatile substances reported within this study may be toxic and have negative impact on human body functions. Further studies are required to investigate if VOCs responding to HD treatment could be used as markers for monitoring hemodialysis efficiency.

Original languageEnglish
Article number43
Number of pages14
JournalBMC Nephrology
Volume15
Issue number1
DOIs
Publication statusPublished - 8 Mar 2014

Fingerprint

Volatile Organic Compounds
Chronic Kidney Failure
Renal Dialysis
Exhalation
Acrolein
Heterocyclic Compounds
Solid Phase Microextraction
Thiophenes
Poisons
Sulfides
Hydrocarbons
Benzene
Ketones
Human Body
Aldehydes
Gas Chromatography
Dialysis
Therapeutics
Air

Keywords

  • Blood analysis
  • Breath analysis
  • End-stage renal disease
  • Hemodialysis
  • Uremic syndrome
  • Volatile organic compounds

ASJC Scopus subject areas

  • Nephrology

Cite this

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. / Mochalski, Paweł; King, Julian; Haas, Matthias; Unterkofler, Karl; Amann, Anton; Mayer, Gert.

In: BMC Nephrology, Vol. 15, No. 1, 43, 08.03.2014.

Research output: Contribution to journalArticleResearchpeer-review

Mochalski, Paweł ; King, Julian ; Haas, Matthias ; Unterkofler, Karl ; Amann, Anton ; Mayer, Gert. / Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. In: BMC Nephrology. 2014 ; Vol. 15, No. 1.
@article{76ab2395d13648efaf6538952622e8b9,
title = "Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease",
abstract = "Background: Monitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment. Methods. Gas chromatography with mass spectrometric detection coupled with solid-phase microextraction as pre-concentration method. Results: A total of 60 VOCs were reliably identified and quantified in blood and breath of CKD patients. Excluding contaminants, six compounds (isoprene, dimethyl sulfide, methyl propyl sulfide, allyl methyl sulfide, thiophene and benzene) changed their blood and breath levels during the hemodialysis treatment. Conclusions: Uremic breath and blood patterns were found to be notably affected by the contaminants from the extracorporeal circuits and hospital room air. Consequently, patient exposure to a wide spectrum of volatile species (hydrocarbons, aldehydes, ketones, aromatics, heterocyclic compounds) is expected during hemodialysis. Whereas highly volatile pollutants were relatively quickly removed from blood by exhalation, more soluble ones were retained and contributed to the uremic syndrome. At least two of the species observed (cyclohexanone and 2-propenal) are uremic toxins. Perhaps other volatile substances reported within this study may be toxic and have negative impact on human body functions. Further studies are required to investigate if VOCs responding to HD treatment could be used as markers for monitoring hemodialysis efficiency.",
keywords = "Blood analysis, Breath analysis, End-stage renal disease, Hemodialysis, Uremic syndrome, Volatile organic compounds",
author = "Paweł Mochalski and Julian King and Matthias Haas and Karl Unterkofler and Anton Amann and Gert Mayer",
year = "2014",
month = "3",
day = "8",
doi = "10.1186/1471-2369-15-43",
language = "English",
volume = "15",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease

AU - Mochalski, Paweł

AU - King, Julian

AU - Haas, Matthias

AU - Unterkofler, Karl

AU - Amann, Anton

AU - Mayer, Gert

PY - 2014/3/8

Y1 - 2014/3/8

N2 - Background: Monitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment. Methods. Gas chromatography with mass spectrometric detection coupled with solid-phase microextraction as pre-concentration method. Results: A total of 60 VOCs were reliably identified and quantified in blood and breath of CKD patients. Excluding contaminants, six compounds (isoprene, dimethyl sulfide, methyl propyl sulfide, allyl methyl sulfide, thiophene and benzene) changed their blood and breath levels during the hemodialysis treatment. Conclusions: Uremic breath and blood patterns were found to be notably affected by the contaminants from the extracorporeal circuits and hospital room air. Consequently, patient exposure to a wide spectrum of volatile species (hydrocarbons, aldehydes, ketones, aromatics, heterocyclic compounds) is expected during hemodialysis. Whereas highly volatile pollutants were relatively quickly removed from blood by exhalation, more soluble ones were retained and contributed to the uremic syndrome. At least two of the species observed (cyclohexanone and 2-propenal) are uremic toxins. Perhaps other volatile substances reported within this study may be toxic and have negative impact on human body functions. Further studies are required to investigate if VOCs responding to HD treatment could be used as markers for monitoring hemodialysis efficiency.

AB - Background: Monitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment. Methods. Gas chromatography with mass spectrometric detection coupled with solid-phase microextraction as pre-concentration method. Results: A total of 60 VOCs were reliably identified and quantified in blood and breath of CKD patients. Excluding contaminants, six compounds (isoprene, dimethyl sulfide, methyl propyl sulfide, allyl methyl sulfide, thiophene and benzene) changed their blood and breath levels during the hemodialysis treatment. Conclusions: Uremic breath and blood patterns were found to be notably affected by the contaminants from the extracorporeal circuits and hospital room air. Consequently, patient exposure to a wide spectrum of volatile species (hydrocarbons, aldehydes, ketones, aromatics, heterocyclic compounds) is expected during hemodialysis. Whereas highly volatile pollutants were relatively quickly removed from blood by exhalation, more soluble ones were retained and contributed to the uremic syndrome. At least two of the species observed (cyclohexanone and 2-propenal) are uremic toxins. Perhaps other volatile substances reported within this study may be toxic and have negative impact on human body functions. Further studies are required to investigate if VOCs responding to HD treatment could be used as markers for monitoring hemodialysis efficiency.

KW - Blood analysis

KW - Breath analysis

KW - End-stage renal disease

KW - Hemodialysis

KW - Uremic syndrome

KW - Volatile organic compounds

UR - http://www.scopus.com/inward/record.url?scp=84897404078&partnerID=8YFLogxK

U2 - 10.1186/1471-2369-15-43

DO - 10.1186/1471-2369-15-43

M3 - Article

VL - 15

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

M1 - 43

ER -